Princeton Global Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$256K Sell
1,616
-15
-0.9% -$2.03K 0.04% 193
2026
Q1
$208K Buy
+1,631
New +$204K 0.03% 198
2024
Q4
Sell
-650
Closed -$64.2K 687
2024
Q3
$64.2K Hold
650
0.01% 287
2024
Q2
$60.3K Hold
650
0.01% 269
2024
Q1
$61.7K Hold
650
0.01% 237
2023
Q4
$58K Hold
650
0.01% 246
2023
Q3
$47.5K Sell
650
-500
-43% -$39.9K 0.01% 258
2023
Q2
$95.7K Hold
1,150
0.03% 202
2023
Q1
$87.6K Hold
1,150
0.03% 215
2022
Q4
$95K Hold
1,150
0.03% 190
2022
Q3
$91K Hold
1,150
0.03% 194
2022
Q2
$85K Hold
1,150
0.03% 211
2022
Q1
$103K Hold
1,150
0.03% 202
2021
Q4
$129K Buy
+1,150
New +$139K 0.04% 192

Other funds holding XBI

Princeton Global Asset Management's XBI Position: Q2 2026 in Review

Princeton Global Asset Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.92% in Q2 2026, selling an estimated $2.03K and leaving 1,616 shares worth $256K. The position accounts for 0.04% of the portfolio, ranked #193.

Princeton Global Asset Management first reported a position in XBI in Q4 2021 and has held it in 14 quarters since. 131 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Princeton Global Asset Management held 1,616 shares of State Street SPDR S&P Biotech ETF worth $256K as of Q2 2026.
  • Princeton Global Asset Management sold 15 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $2.03K.
  • State Street SPDR S&P Biotech ETF made up 0.04% of Princeton Global Asset Management's portfolio in Q2 2026, its #193 holding.
  • Princeton Global Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 14 quarters since.
  • 131 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Princeton Global Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.